High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor- risk germ cell tumors Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Marrow Transplantation
  • Germinoma

abstract

  • In this setting, high-dose CEC was well tolerated, cumulative toxicity was lacking, and the recovery of blood counts after AuBMT was rapid. A randomized trial has been initiated to investigate further the role of high-dose CEC in first-line therapy for patients with poor-risk GCT.

publication date

  • July 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9215823

Additional Document Info

start page

  • 2546

end page

  • 52

volume

  • 15

number

  • 7